Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma.

Item

http://www.wikidata.org/entity/Q38880504

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Plerixafor injection: a hemato ...... lymphoma and multiple myeloma.

@en

type

Item

label

Plerixafor injection: a hemato ...... lymphoma and multiple myeloma.

@en

prefLabel

Plerixafor injection: a hemato ...... lymphoma and multiple myeloma.

@en

P1476

Plerixafor injection: a hemato ...... lymphoma and multiple myeloma

@en

P2093

Esa Jantunen

http://www.w3.org/2001/XMLSchema#string

Jaakko Valtola

http://www.w3.org/2001/XMLSchema#string

P2860

Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization

Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma.

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.

P304

723-732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474086.2016.1208082

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ville Varmavuo

P577

2016-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27355397

http://www.w3.org/2001/XMLSchema#string